MIXED LINEAGE ACUTE LEUKEMIA
Clinical trials for MIXED LINEAGE ACUTE LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new MIXED LINEAGE ACUTE LEUKEMIA trials appear
Sign up with your email to follow new studies for MIXED LINEAGE ACUTE LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough leukemia: experimental drug targets genetic flaw
Disease control OngoingThis study tests a new drug called ziftomenib (KO-539) in people with acute myeloid leukemia (AML) that has come back or not responded to treatment. The drug targets a specific genetic change (MLL rearrangement or NPM1 mutation) found in some patients. The goal is to find the saf…
Matched conditions: MIXED LINEAGE ACUTE LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Kura Oncology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New stem cell method shows promise for young blood cancer patients
Disease control OngoingThis study tests a new way to do stem cell transplants for children and young adults (up to age 22) with blood cancers like leukemia. Doctors remove certain immune cells from donated stem cells to lower the risk of graft-versus-host disease, a serious complication. The goal is to…
Matched conditions: MIXED LINEAGE ACUTE LEUKEMIA
Phase: PHASE2 • Sponsor: Julie-An M. Talano • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New stem cell method aims to cut transplant risks for blood cancer patients
Disease control OngoingThis study tests a stem cell transplant method that removes certain immune cells (T and B cells) from donated stem cells before giving them to patients with blood cancers like leukemia or lymphoma. The goal is to help the new cells grow (engraft) while reducing the risk of graft-…
Matched conditions: MIXED LINEAGE ACUTE LEUKEMIA
Phase: PHASE2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC